Current Research Information SysTem In Norway
 
 

 Norsk versjon


 
Mainpage
Research results/NVI
Researchers
Projects
Research units
Log in
About Cristin
 
 
   
Back to search     Short format     Full format    
Export to


Showing results 1-43 of 43

2022
1 Pedersen, Christine Aaserød; Cao, Maria Dung; Fleischer, Thomas; Rye, Morten Beck; Knappskog, Stian; Eikesdal, Hans Petter; Lønning, Per Eystein; Tost, Jörg; Kristensen, Vessela N.; Tessem, May-Britt; Giskeødegård, Guro F.; Bathen, Tone Frost.
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival. Breast Cancer Research 2022 ;Volume 24:43.(1) p. 1-14
UiO NTNU HIOF OUS STO UiB HAUKELAND Untitled
 
2019
2 Madssen, Torfinn Støve; Cao, Maria Dung; Pladsen, Arne Valebjørg; Ottestad, Lars; Sahlberg, Kristine Kleivi; Bathen, Tone Frost; Giskeødegård, Guro F..
Historical Biobanks in Breast Cancer Metabolomics — Challenges and Opportunities. Metabolites 2019 ;Volume 9.(11) p. -
OUS OSTFSYK VV NTNU Untitled
 
2017
3 Volchenkov, Roman; Cao, Maria Dung; Elgstøen, Katja B. Prestø; Goll, Guro Løvik; Eikvar, Kari; Bjørneboe, Olav; Bathen, Tone Frost; Holen, Halvor Laustad; Kvien, Tore Kristian; Skålhegg, Bjørn Steen.
Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples. Scandinavian Journal of Rheumatology 2017 ;Volume 46.(2) p. 160-161
DIAKON MHH OUS NTNU UiO Untitled
 
2016
4 Cao, Maria Dung; Cheng, Menglin; Rizwan, Asif; Jiang, Lu; Krishnamachary, Balaji; Bhujwalla, Zaver M.; Bathen, Tone Frost; Glunde, Kristine.
Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion. NMR in Biomedicine 2016 ;Volume 29.(8) p. 1098-1107
NTNU STO Untitled
 
2015
5 Cao, Maria Dung.
MR i kliniske og prekliniske studier av brystkreft. Mammakurs for bryst- og endokrinkirurger 2015; 2015-05-18 - 2015-05-18
NTNU Untitled
 
6 Giskeødegård, Guro F.; Cao, Maria Dung; Bathen, Tone Frost.
High-Resolution Magic-Angle-Spinning NMR Spectroscopy of Intact Tissue. Methods in molecular biology 2015 ;Volume 1277. p. 37-50
STO NTNU Untitled
 
2014
7 Cao, Maria Dung.
The potential and challenges of HR MAS MRS in characterization of breast cancer. ISMRM Cancer Workshop 2014; 2014-11-06 - 2014-11-09
NTNU Untitled
 
8 Cao, Maria Dung; Bathen, Tone Frost; Giskeødegård, Guro F..
Methylation, metabolomics and response. Kongsvold møte; 2014-09-15 - 2014-09-17
NTNU Untitled
 
9 Cao, Maria Dung; Cheng, Menglin; Jiang, Lu; Greenwood, Tiffany; Krishnamachary, Balaji; Bhujwalla, Zaver M.; Bathen, Tone Frost; Glunde, Kristine.
Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decreases breast cancer cell proliferation and invasion. ISMRM 2014; 2014-05-10 - 2014-05-16
NTNU Untitled
 
10 Cao, Maria Dung; Giskeødegård, Guro F..
Behandling av aggressiv brystkreft- finnes svaret i våre metabolitter?.
NTNU Untitled
 
11 Cao, Maria Dung; Lamichhane, Santosh; Lundgren, Steinar; Bofin, Anna M.; Fjøsne, Hans Erikssønn; Giskeødegård, Guro F.; Bathen, Tone Frost.
Metabolic characterization of triple negative breast cancer. BMC Cancer 2014 ;Volume 14. p. 941-
NTNU STO Untitled
 
12 Gadiya, Mayur M.; Mori, N; Cao, Maria Dung; Mironchik, Y; Kakkad, S; Gribbestad, Ingrid S; Glunde, Kristine; Krishnamachary, Balaji; Bhujwalla, Zaver M..
Phospholipase D1 and choline kinase-α are interactive targets in breast cancer. Cancer Biology & Therapy 2014 ;Volume 15.(5) p. 593-601
NTNU Untitled
 
13 Giskeødegård, Guro F.; Cao, Maria Dung; Lamichane, Santosh; Sitter, Beathe; Bofin, Anna M.; Lundgren, Steinar; Fjøsne, Hans Erikssønn; Bathen, Tone Frost.
Metabolic characterization of triple negative breast cancer. Joint annual meeting ISMRM-ESMRMB; 2014-05-10 - 2014-05-16
NTNU Untitled
 
14 Huynh, Bao-Mai.
Metabolic and Histopathological characterization of Prostate cancer. Trondheim: NTNU 2014 69 p.
NTNU Untitled
 
15 Sjøbakk, Torill Eidhammer; Hill, Deborah Katherine; Strypet, Hanne; Skjærvik, Linda; Evensmoen, Hallvard Røe; Selnæs, Kirsten Margrete; Moestue, Siver Andreas; Bathen, Tone Frost; Berger, Hester Rijkje; Cao, Maria Dung; Austdal, Marie; Elschot, Mattijs; Haukaas, Tonje Husby.
MAGNETER OG MEDISIN Stand i samarbeid med Kreftforeingen v/Linda Skjærvik. Forskningstorget; 2014-09-19 - 2014-09-20
NTNU Untitled
 
16 Wijnen, Jannie p; Jiang, L; Greenwood, TR; Cheng, M; Dopkens, M; Cao, Maria Dung; Bhujwalla, Zaver M.; Krishnamachary, Balaji; Klomp, Dennis WJ; Glunde, Kristine.
Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by 31P MRS. NMR in Biomedicine 2014 ;Volume 27.(6) p. 692-699
NTNU Untitled
 
2013
17 Cao, Maria Dung.
Breast cancer research beyond borders.
NTNU Untitled
 
18 Cao, Maria Dung.
The potential role of Metabolomics in breast cancer diagnosis and prognosis. Metabolomics seminar 2013; 2013-09-26 - 2013-09-26
NTNU Untitled
 
19 Cao, Maria Dung; Giskeødegård, Guro F.; Santosh, Lamichhane; Sitter, Beathe; Lundgren, Steinar; Bofin, Anna M.; Fjøsne, Hans E.; Gribbestad, Ingrid S; Bathen, Tone.
Metabolic characterization of triple negative breast cancer. ISMRM cancer workshop 2013; 2013-02-19 - 2013-02-22
NTNU Untitled
 
20 Shiva Shojaei, Moghaddam.
Metabolic characterization of locally advanced breast cancer in response to NAC treatment based on HR MAS MRS. : NTNU 2013 63 p.
NTNU Untitled
 
2012
21 Cao, Maria Dung.
MR metabolic characterization of locally advanced breast cancer - treatment effects and prognosis. Trondheim: NTNU-trykk 2012 (ISBN 978-82-471-3420-7) 53 p.
NTNU Untitled
 
22 Cao, Maria Dung.
Prediksjon av behandlingsrespons og overlevelse i pasienter med lokalavansert brystkreft. Best Practice Onkologi/Hematologi 2012 (8)
NTNU Untitled
 
23 Cao, Maria Dung; Döpkens, Mailin; Krishnamachary, Balaji; Vesuna, Farhad; Gadiya, Mayur M.; Lønning, Per Eystein; Bhujwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR in Biomedicine 2012 ;Volume 25.(9) p. 1033-1042
NTNU HAUKELAND UiB Untitled
 
24 Cao, Maria Dung; Giskeødegård, Guro F..
Metabolomics of cancer tissue. Internundervisning; 2012-10-18 - 2012-10-18
NTNU Untitled
 
25 Cao, Maria Dung; Giskeødegård, Guro F.; Bathen, Tone Frost; Sitter, Beathe; Bofin, Anna M.; Lønning, Per Eystein; Lundgren, Steinar; Gribbestad, Ingrid S.
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. Kongsvold møte; 2012-08-29 - 2012-08-30
HAUKELAND NTNU Untitled
 
26 Cao, Maria Dung; Giskeødegård, Guro F.; Bathen, Tone Frost; Sitter, Beathe; Bofin, Anna M.; Lønning, Per Eystein; Lundgren, Steinar; Gribbestad, Ingrid S.
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer 2012 ;Volume 12. p. -
NTNU STO HAUKELAND UiB Untitled
 
27 Cao, Maria Dung; Jiang, Lu; Blackwell, Tiffany; Krishnamachary, Balaji; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
Metabolic response to glycerophosphocholine phosphodiesterase GDPD5 silencing in human breast cancer cells. Metabomeeting 2012; 2012-09-25 - 2012-09-27
NTNU Untitled
 
28 Cao, Maria Dung; Jiang, Lu; Blackwell, Tiffany; Krishnamachary, Balaji; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
Metabolic response to glycerophosphocholine phosphodiesterase GDPD5 silencing in human breast cancer cells. Personalized cancer care 2012; 2012-09-07 - 2012-09-09
NTNU Untitled
 
29 Cao, Maria Dung; Jiang, Lu; Blackwell, Tiffany; Krishnamachary, Balaji; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
siRNA-mediated silencing of the glycerophosphocholine phosphodiesterase GDPD5 in breast cancer cells. ISMRM annual scientific meeting 2012; 2012-05-05 - 2012-05-11
NTNU Untitled
 
30 Cao, Maria Dung; Jiang, Lu; Blackwell, Tiffany; Krishnamachary, Balaji; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
siRNA-mediated silencing of the glycerophosphocholine phosphodiesterase GDPD5 in breast cancer cells. Regional forskningskonferanse HMN 2012; 2012-06-05 - 2012-06-06
NTNU Untitled
 
31 Cao, Maria Dung; Jiang, Lu; Blackwell, Tiffany; Krishnamachary, Balaji; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
siRNA-mediated silencing of the glycerophosphocholine phosphodiesterase GDPD5 in breast cancer cells. Opening of MR Core Facility; 2012-10-23 - 2012-10-23
NTNU Untitled
 
32 Cao, Maria Dung; Sitter, Beathe; Bathen, Tone Frost; Bofin, Anna M.; Lønning, Per Eystein; Lundgren, Steinar; Gribbestad, Ingrid S.
Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR in Biomedicine 2012 ;Volume 25.(2) p. 369-378
NTNU HAUKELAND UiB STO Untitled
 
33 Moestue, Siver Andreas; Giskeødegård, Guro F.; Cao, Maria Dung; Bathen, Tone Frost; Gribbestad, Ingrid S.
Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer. Proceedings of the National Academy of Sciences of the United States of America 2012 ;Volume 109.(38) p. E2506-E2506
NTNU Untitled
 
34 Wijnen, Jannie p; Jiang, Lu; Blackwell, Tiffany; Cao, Maria Dung; Krishnamachary, Balaji; Klomp, Dennis WJ; Glunde, Kristine.
Magnetic Resonance Spectroscopy study on the effects of stably silencing the glycerophosphocholine phosphodiesterase GDPD5 in a breast cancer model in vivo. ISMRM annual scientific meeting 2012; 2012-05-05 - 2012-05-11
NTNU Untitled
 
2011
35 Cao, Maria Dung; Jiang, Lu; Krishnamachary, Balaji; Doepkens, Mailin; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
Effects of targeting the glycerophosphocholine phosphodiesterase GDPD5 in breast cancer models. ISMRM 2011; 2011-05-07 - 2011-05-13
NTNU Untitled
 
36 Cao, Maria Dung; Jiang, Lu; Krishnamachary, Balaji; Doepkens, Mailin; Vesuna, Farhad; Lønning, Per Eystein; Bhjuwalla, Zaver M.; Gribbestad, Ingrid S; Glunde, Kristine.
GDPD5 expression correlates with choline metabolite profiles in human breast cancer. FUGE workshop; 2011-09-07 - 2011-09-09
HAUKELAND NTNU Untitled
 
2010
37 Cao, Maria Dung.
Predicting treatment response and long-term breast cancer survival by HR MAS MRS metabolic profiling. In Vivo Cellular Molecular Imaging Center, Johns Hopkins University, USA; 2010-07-07 - 2010-07-07
NTNU Untitled
 
38 Cao, Maria Dung; Ljiang, Lu; Doepkens, Mailin; Krishnamachary, Balaji; Blackwell, Tiffany; Bhujwalla, Zaver; Gribbestad, Ingrid S; Glunde, Kristine.
Silencing the glycerophosphocholine phosphodiesterase GDPD5 reduced breast tumor growth and modulated tumor choline phospholipid metabolism. ISMRM MR Cancer workshop; 2010-09-19 - 2010-09-22
NTNU Untitled
 
39 Cao, Maria Dung; Sitter, Beathe; Bathen, Tone Frost; Bofin, Anna M.; Lønning, Per Eystein; Lundgren, Steinar; Gribbestad, Ingrid S.
Predicting long-term breast cancer survival in patients receiving neoadjuvant chemotherapy by MR metabolic profiling. MI Lab day; 2010-04-29
NTNU UiB Untitled
 
40 Cao, Maria Dung; Sitter, Beathe; Bathen, Tone Frost; Bofin, Anna M.; Lønning, Per Eystein; Lundgren, Steinar; Gribbestad, Ingrid S.
Predicting long-term survival for breast cancer patients by HR MAS metabolic profiling during neoadjuvant chemotherapy. ISMRM 2010; 2010-05-01 - 2010-05-07
NTNU UiB Untitled
 
2009
41 Bathen, Tone Frost; Cao, Maria Dung; Sitter, Beathe; Lønning, Per E.; Lundgren, Steinar; Gribbestad, Ingrid S.
MR metabolomics – a tool in detection of biomarkers for response to neoadjuvant chemotherapy in local advanced breast cancer?. ESMRMB 2009 Congress; 2009-10-01 - 2009-10-03
NTNU Untitled
 
42 Cao, Maria Dung; Sitter, Beathe; Bathen, Tone Frost; Lønning, Per E.; Lundgren, Steinar; Gribbestad, Ingrid S.
Choline metabolites as biomarkers for predicting response to neoadjuvant chemotherapy in local advanced breast cancer patients. ISMRM; 2009-04-18 - 2009-04-24
NTNU Untitled
 
43 Heldahl, Mariann Gjervik; Sitter, Beathe; Bathen, Tone Frost; Cao, Maria Dung; Lundgren, Steinar; Gribbestad, Ingrid S.
In vivo and ex vivo choline metabolite profiles as biomarkers for treatment response in locally advanced breast cancer. ISMRM; 2009-04-18 - 2009-04-24
NTNU Untitled